Hormone Therapy in Prostate Cancer -- Sloan-Kettering

Hormone therapy used to be the last line of defense against metastatic prostate cancer, but doctors are increasingly using it earlier in treatment because of its benefits when added to radiation therapy. However, blocking the production of testosterone is not the best approach for every patient. Michael Morris, MD, of Memorial Sloan-Kettering Cancer Center discusses the potential side effects of hormone therapy, and the potential benefits and risks for individual patients.

For more information, please visit http://www.mskcc.org/prostatecancer

Category:

Science & Technology

Tags:

• prostate cancer
• hormone therapy
• hormonal therapy
• testosterone
• andropause
• Memorial Sloan-Kettering
• Michael Morris
• Max Gomez